Literature DB >> 8954056

Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease.

S Arif1, S Vallian, F Farzaneh, M M Zanone, S L James, M Pietropaolo, S Hettiarachchi, D Vergani, G S Conway, M Peakman.   

Abstract

Autoantibodies directed against steroid hormone-producing cells (SCA) detectable by immunofluorescence are typically found in a small proportion of patients with premature ovarian failure (POF) as well as in other endocrine autoimmune diseases. The SCA pattern stains cells in the outer zones of the adrenal cortex, ovary, and testis. To identify the molecular target of SCA, an adrenal complementary DNA expression library was screened using SCA-positive serum, and the steroid enzyme 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) was identified. Only 1 of 48 (2%) patients with idiopathic POF, not pre-selected for the presence of other autoimmune diseases, had SCA by immunofluorescence, whereas 10 of 48 (21%) had anti-3 beta HSD autoantibodies detectable by immunoblot using recombinant human enzyme compared with 6 of 115 (5%) control subjects (P = 0.002). Absorption of SCA-positive serum with recombinant human 3 beta HSD abolished the immunofluorescence pattern. We also examined the prevalence of anti-3 beta HSD autoantibodies in other endocrine autoimmune diseases. Two of 112 (2%) diabetic patients, but none of the thyroid or Addisonian patients, had SCA by immunofluorescence. Twenty-six (23%) diabetic subjects (P < 0.001 vs. controls), 3 of 18 thyroid patients (P > 0.05 vs. controls), and none of 4 Addisonian patients had anti-3 beta HSD autoantibodies. 3 beta HSD is the first steroid cell autoantigen defined at the molecular level to be associated with idiopathic POF occurring in the absence of other polyglandular diseases. Autoantibodies to 3 beta HSD in patients with other organ-specific autoimmune diseases indicate that the enzyme behaves as a typical target of polyendocrine autoimmunity. Anti-3 beta HSD autoantibodies in patients with POF may provide a marker of those subjects whose ovarian failure is autoimmune in origin and, as recent studies suggest, may be salvageable with glucocorticoid treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954056     DOI: 10.1210/jcem.81.12.8954056

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Multiplicity of molecular and cellular targets in human ovarian autoimmunity: an update.

Authors:  Eusebio S Pires
Journal:  J Assist Reprod Genet       Date:  2010-06-03       Impact factor: 3.412

2.  Induction and immunohistology of autoimmune ovarian disease in cynomolgus macaques (Macaca fascicularis).

Authors:  Harini Bagavant; Colin Sharp; Barbara Kurth; Kenneth S K Tung
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 3.  Ovarian autoimmune disease: clinical concepts and animal models.

Authors:  Bryce D Warren; William K Kinsey; Lynda K McGinnis; Lane K Christenson; Susmita Jasti; Anne M Stevens; Brian K Petroff; Margaret G Petroff
Journal:  Cell Mol Immunol       Date:  2014-10-20       Impact factor: 11.530

Review 4.  A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency.

Authors:  A Falorni; V Minarelli; C M Eads; C M Joachim; L Persani; R Rossetti; P Yurttas Beim; V A Pellegrini; P F Schnatz; S Rafique; K Kissell; K A Calis; V Popat; L M Nelson
Journal:  Panminerva Med       Date:  2014-10-07       Impact factor: 5.197

Review 5.  Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone.

Authors:  Kadri Haller-Kikkatalo; Andres Salumets; Raivo Uibo
Journal:  Clin Dev Immunol       Date:  2011-10-05

Review 6.  Pathogenesis and causes of premature ovarian failure: an update.

Authors:  Mahbod Ebrahimi; Firoozeh Akbari Asbagh
Journal:  Int J Fertil Steril       Date:  2011-09-23

Review 7.  The role of autoimmunity in premature ovarian failure.

Authors:  Mahbod Ebrahimi; Firouzeh Akbari Asbagh
Journal:  Iran J Reprod Med       Date:  2015-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.